Bone rarefaction and crush fractures in juvenile chronic arthritis.

Geahča maid

• Deflazacort in juvenile chronic arthritis.
  Dahkki: Loftus, J, et al.
  Almmustuhtton: (1993)
• Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids.
  Dahkki: Reeve, J, et al.
  Almmustuhtton: (1993)
• Spinal and somatic growth in patients with juvenile chronic arthritis treated for up to 2 years with deflazacort.
  Dahkki: David, J, et al.
  Almmustuhtton: (1992)
• Bone mineral content and bone mineral metabolism: changes after growth hormone treatment in juvenile chronic arthritis.
  Dahkki: Rooney, M, et al.
  Almmustuhtton: (2000)
• Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
  Dahkki: Loftus, J, et al.
  Almmustuhtton: (1991)